Factor VIIa: Difference between revisions

From Proteopedia
Jump to navigationJump to search
No edit summary
Michal Harel (talk | contribs)
No edit summary
 
(9 intermediate revisions by 2 users not shown)
Line 1: Line 1:
<StructureSection load='1dan' size='350' side='right' scene='39/399790/Cv/2' caption='Human factor VIIa heavy chain (pink) and light chain (cyan) complex with soluble tissue factor (dark red, dark green) and a peptide inhibitor, cacodylate, Cl- and Ca+2 ions [[1dan]]'>
<StructureSection load='1dan' size='350' side='right' scene='39/399790/Cv/2' caption='Human factor VIIa heavy chain (pink) and light chain (cyan) complex with soluble tissue factor (dark red, dark green) and a peptide inhibitor, cacodylate, Cl- and Ca+2 ions [[1dan]]'>
__TOC__
==Function==


[[Factor VIIa]] (FVIIa) is a single chain trypsin-like serine protease [http://en.wikipedia.org/wiki/Serine_protease](EC 3.4.21.21) of 406 residues. The FVII[http://en.wikipedia.org/wiki/Factor_VIIa] zymogen is a glycoprotein consisting of an amino-terminal (N-linked) γ-carboxyglutamic acid (Gla)[http://en.wikipedia.org/wiki/Carboxyglutamic_acid]domain followed by two epidermal growth factor-like (EGF1 and EGF2) domains, a short linker peptide, and a carboxy terminal serine protease domain<ref>PMID:10430872</ref>. The active form, FVIIa, is generated by a specific cleavage of a peptide bond between Arg152 and Ile153 at the end of the linker peptide by either factor Xa (FXa) or thrombin (IIa). This cleavage generates an N-terminal light chain of 152 residues linked to a heavy chain of 254 residues by a disulfide bridge <ref>PMID:6778860</ref>. Following cleavage the newly formed N-terminal inserts itself into a cavity, or the activation pocket, forming a salt bridge with Asp343 (Asp194 trypsin numbering).Formation of this salt bridge allows for the maturation of FVIIa to its active form. The images correspond to one representative Factor VIIa, ''i.e.'' the crystal structure of Human factor VIIa complex with tissue factor and a peptide inhibitor ([[1dan]]).
[[Factor VIIa]] (FVIIa) is a single chain trypsin-like serine protease [http://en.wikipedia.org/wiki/Serine_protease](EC 3.4.21.21) of 406 residues. The FVII[http://en.wikipedia.org/wiki/Factor_VIIa] zymogen is a glycoprotein consisting of an amino-terminal (N-linked) γ-carboxyglutamic acid (Gla)[http://en.wikipedia.org/wiki/Carboxyglutamic_acid]domain followed by two epidermal growth factor-like (EGF1 and EGF2) domains, a short linker peptide, and a carboxy terminal serine protease domain<ref>PMID:10430872</ref>. The active form, FVIIa, is generated by a specific cleavage of a peptide bond between Arg152 and Ile153 at the end of the linker peptide by either factor Xa (FXa) or thrombin (IIa). This cleavage generates an N-terminal light chain of 152 residues linked to a heavy chain of 254 residues by a disulfide bridge <ref>PMID:6778860</ref>. Following cleavage the newly formed N-terminal inserts itself into a cavity, or the activation pocket, forming a salt bridge with Asp343 (Asp194 trypsin numbering).Formation of this salt bridge allows for the maturation of FVIIa to its active form. The images correspond to one representative Factor VIIa, ''i.e.'' the crystal structure of Human factor VIIa complex with tissue factor and a peptide inhibitor ([[1dan]]).


<scene name='39/399790/Cv/3'>Human factor VIIa heavy chain and light chain</scene> complex with <scene name='39/399790/Cv/4'>soluble tissue factor, chains T and U</scene>.
<scene name='39/399790/Cv/10'>Human factor VIIa heavy chain and light chain</scene> complex with <scene name='39/399790/Cv/4'>soluble tissue factor, chains T and U</scene>.


<scene name='39/399790/Cv/7'>Peptide inhibitor FFRCK binding site</scene>.
<scene name='39/399790/Cv/11'>Peptide inhibitor FFRCK binding site</scene>.


<scene name='39/399790/Cv/8'>Cacodylate binding site</scene>.
<scene name='39/399790/Cv/12'>Cacodylate binding site</scene>.


<scene name='39/399790/Cv/9'>Ca+2 ions binding with modified residues gamma-carboxy-glutamic acids</scene> ([[1dan]]).<ref>PMID:8598903</ref>
<scene name='39/399790/Cv/13'>Ca+2 ions binding with modified residues gamma-carboxy-glutamic acids</scene> ([[1dan]]).<ref>PMID:8598903</ref> Water molecules are shown as red spheres.
==FVIIa mechanism==
==FVIIa mechanism==
===General===
===General===


FVIIa alone shows very little proteolytic activity and only becomes fully active when complexed to its obligatory cofactor, tissue factor (TF) and cations, mainly Ca++. TF, located in the vessel wall, is exposed to circulating FVIIa upon injury or some type of stimulus and forms a TF-FVIIa complex. A unique property of TF-FVIIa among other coagulation enzyme complexes is that phospholipids are not an obligate requirement for the assembly of the complex. However, the activity of the complex towards its substrates (FIX and FX) requires a lipid surface which is provided by the membrane-anchored TF. The TF-phospholipid complex enhances the efficiency (kcat/Km) of FVIIa-catalyzed reactions by the 10^10-fold. There are four distinct steps that are required for the full activity of the TF-FVIIa complex: 1) proteolytic activation of single-chained FVII to two-chain disulfide bridged FVIIa 2) binding of cations 3) interaction of TF with FVIIa 4) acidic-membrane association and proper orientation of substrate<ref>PMID:1537862</ref><ref>PMID:18640965</ref>.  
FVIIa alone shows very little proteolytic activity and only becomes fully active when complexed to its obligatory cofactor, tissue factor (TF) and cations, mainly Ca++. TF, located in the vessel wall, is exposed to circulating FVIIa upon injury or some type of stimulus and forms a TF-FVIIa complex. A unique property of TF-FVIIa among other coagulation enzyme complexes is that phospholipids are not an obligate requirement for the assembly of the complex. However, the activity of the complex towards its substrates (FIX and FX) requires a lipid surface which is provided by the membrane-anchored TF. The TF-phospholipid complex enhances the efficiency (kcat/Km) of FVIIa-catalyzed reactions by the 10^10-fold. There are four distinct steps that are required for the full activity of the TF-FVIIa complex: 1) proteolytic activation of single-chained FVII to two-chain disulfide bridged FVIIa 2) binding of cations 3) interaction of TF with FVIIa 4) acidic-membrane association and proper orientation of substrate<ref>PMID:1537862</ref><ref>PMID:18640965</ref>.  
See also [[Mg-8 may contribute to the binding to factors VIIa and X]].
[[Image:FVIIa-TF_FX.jpg|left|thumb|450px]]
[[Image:FVIIa-TF_FX.jpg|left|thumb|450px]]
{{Clear}}
{{Clear}}
Line 61: Line 65:


[[Image:catalytic domain.jpg|left|thumb|450px]]
[[Image:catalytic domain.jpg|left|thumb|450px]]
</StructureSection>
== 3D Structures of Factor VIIa ==


Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}}
{{#tree:id=OrganizedByTopic|openlevels=0|


*Factor VIIa


**[[1klj]] – hVIIa - human<br />
**[[1f7e]], [[1f7m]], [[1ff7]], [[1ffm]], [[1bf9]] – hVIIa EGF-like domain - NMR<br />


*Factor VIIa with inhibitor complex


**[[1cvw]] - hVIIa + EG-ARM<br />
**[[2bz6]], [[1w7x]], [[1w8b]], [[1ygc]], [[1kli]], [[4ish]], [[4isi]], [[4jyu]], [[4jyv]], [[4jzd]], [[4jze]], [[4jzf]], [[4ng9]], [[4nga]], [[4x8s]], [[4x8t]], [[4x8u]], [[4x8v]], [[4yt6]], [[4yt7]], [[4zxx]], [[4zxy]], [[5tqe]], [[5tqf]], [[5tqg]] - hVIIa + inhibitor<br />
**[[1qfk]] - hVIIa + DPN-FR<br />


*Factor VIIa with cofactor complex


**[[2c4f]] - hVIIa precursor + tissue factor<br />
**[[3ela]] - hVIIa (mutant) + tissue factor<br />


*Factor VIIa with cofactor and inhibitor complex


**[[2zzu]], [[2zwl]], [[2zp0]], [[2ec9]], [[2flr]], [[2aei]], [[2aer]], [[2f9b]], [[2b7d]], [[1wv7]], [[1wun]], [[1wtg]], [[1wss]], [[1wqv]], [[1w2k]], [[1z6j]], [[1w0y]] – hVIIa + tissue factor + inhibitor<br />
 
**[[2puq]], [[2fir]], [[2b8o]], [[1dan]] - hVIIa + tissue factor + peptide-CMK<br />
 
**[[1j9c]] - hVIIa + tissue factor + FFR-methylene<br />
 
**[[2a2q]] - hVIIa + tissue factor + cations<br />
 
**[[1jbu]] - hVIIa + tissue factor + peptide exosite inhibitor<br />
 
**[[1dva]] - hVIIa + tissue factor + peptide exosite inhibitor + DPN-FR<br />
 
**[[1fak]] - hVIIa + tissue factor + BPTI (mutant)<br />
 
}}
 
 
 
 
 
 
 
 
 
 
 
 
 
 
== 3D Structures of Factor VIIa ==
[[Factor VIIa 3D structures]]
 
</StructureSection>
 
==Additional Resources==
==Additional Resources==
For additional information, see: [[Hemophilia]]
For additional information, see:  
<br />
*[[Hemophilia]]
*[[Journal:Acta Cryst D:S2059798321003922|Structure of the human factor VIIa/soluble tissue factor with calcium, magnesium and rubidium]]


==References==
==References==

Latest revision as of 08:47, 27 February 2023

Human factor VIIa heavy chain (pink) and light chain (cyan) complex with soluble tissue factor (dark red, dark green) and a peptide inhibitor, cacodylate, Cl- and Ca+2 ions 1dan

Drag the structure with the mouse to rotate

Additional Resources

For additional information, see:

References

Proteopedia Page Contributors and Editors (what is this?)

Jolanta Amblo, Alexander Berchansky, David Canner, Michal Harel